The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Ting ZhaoMichelle TewTalitha FeenstraPieter van BaalMichael WillisWilliam J ValentinePhilip M ClarkeBarnaby HuntJames AltunkayaAn Tran-DuyRichard F PollockSamuel J P MalkinAndreas NilssonPhil McEwanVolker FoosJose LealElbert S HuangNeda LaiteerapongMark LamotteHarry SmolenJianchao QuanLuís MartinsMafalda RamosAndrew J PalmerPublished in: Applied health economics and health policy (2024)
For diabetes, with many costly noncommunicable diseases already explicitly modelled as complications, and with many interventions having predominantly an effect on the improvement of quality of life, unrelated future medical costs have a small impact on the outcomes of health economic evaluations.